Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

NYSE:MIR - New York Stock Exchange, Inc. - US60471A1016 - Common Stock - Currency: USD

20.42  0 (0%)

After market: 20.42 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MIR. MIR was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. MIR has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, MIR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MIR had positive earnings in the past year.
In the past year MIR had a positive cash flow from operations.
MIR had negative earnings in each of the past 5 years.
In the past 5 years MIR always reported a positive cash flow from operatings.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

MIR's Return On Assets of -0.38% is in line compared to the rest of the industry. MIR outperforms 49.60% of its industry peers.
Looking at the Return On Equity, with a value of -0.66%, MIR is in line with its industry, outperforming 50.40% of the companies in the same industry.
The Return On Invested Capital of MIR (1.34%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.38%
ROE -0.66%
ROIC 1.34%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

MIR has a Operating Margin of 4.61%. This is in the better half of the industry: MIR outperforms 63.20% of its industry peers.
MIR's Operating Margin has declined in the last couple of years.
MIR's Gross Margin of 46.97% is amongst the best of the industry. MIR outperforms 80.80% of its industry peers.
MIR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.61%
PM (TTM) N/A
GM 46.97%
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MIR is destroying value.
MIR has more shares outstanding than it did 1 year ago.
MIR has a worse debt/assets ratio than last year.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

MIR has an Altman-Z score of 2.77. This is not the best score and indicates that MIR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.77, MIR is doing worse than 62.40% of the companies in the same industry.
The Debt to FCF ratio of MIR is 8.15, which is on the high side as it means it would take MIR, 8.15 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MIR (8.15) is comparable to the rest of the industry.
MIR has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
MIR has a Debt to Equity ratio of 0.46. This is in the lower half of the industry: MIR underperforms 67.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 8.15
Altman-Z 2.77
ROIC/WACC0.14
WACC9.62%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.23 indicates that MIR has no problem at all paying its short term obligations.
MIR has a Current ratio (2.23) which is in line with its industry peers.
A Quick Ratio of 1.69 indicates that MIR should not have too much problems paying its short term obligations.
MIR has a Quick ratio (1.69) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.69
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.35% over the past year.
The Revenue has been growing slightly by 7.25% in the past year.
MIR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.36% yearly.
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%4.88%

3.2 Future

Based on estimates for the next years, MIR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.50% on average per year.
MIR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.15% yearly.
EPS Next Y17.8%
EPS Next 2Y18.39%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year6.82%
Revenue Next 2Y7.2%
Revenue Next 3Y7.15%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.38 indicates a quite expensive valuation of MIR.
MIR's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.41. MIR is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 35.53, which means the current valuation is very expensive for MIR.
The rest of the industry has a similar Price/Forward Earnings ratio as MIR.
MIR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.38
Fwd PE 35.53
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MIR's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MIR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 56.25
EV/EBITDA 28.18
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MIR's earnings are expected to grow with 19.50% in the coming years.
PEG (NY)2.55
PEG (5Y)N/A
EPS Next 2Y18.39%
EPS Next 3Y19.5%

0

5. Dividend

5.1 Amount

No dividends for MIR!.
Industry RankSector Rank
Dividend Yield N/A

MIRION TECHNOLOGIES INC

NYSE:MIR (7/11/2025, 8:04:01 PM)

After market: 20.42 0 (0%)

20.42

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-31 2025-07-31
Inst Owners82.68%
Inst Owner Change-0.35%
Ins Owners4.41%
Ins Owner Change0.53%
Market Cap4.74B
Analysts84.44
Price Target19.99 (-2.11%)
Short Float %6.28%
Short Ratio4.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.41%
Min EPS beat(2)13.88%
Max EPS beat(2)26.94%
EPS beat(4)3
Avg EPS beat(4)15.21%
Min EPS beat(4)-11.99%
Max EPS beat(4)32.01%
EPS beat(8)6
Avg EPS beat(8)11.49%
EPS beat(12)8
Avg EPS beat(12)6.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.2%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)2.76%
Revenue beat(4)2
Avg Revenue beat(4)0.06%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)2.76%
Revenue beat(8)5
Avg Revenue beat(8)1.58%
Revenue beat(12)7
Avg Revenue beat(12)1.32%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.26%
PT rev (3m)-2%
EPS NQ rev (1m)-1.91%
EPS NQ rev (3m)-10.41%
EPS NY rev (1m)-0.43%
EPS NY rev (3m)2.66%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)-0.92%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 45.38
Fwd PE 35.53
P/S 5.44
P/FCF 56.25
P/OCF 36.8
P/B 3.15
P/tB N/A
EV/EBITDA 28.18
EPS(TTM)0.45
EY2.2%
EPS(NY)0.57
Fwd EY2.81%
FCF(TTM)0.36
FCFY1.78%
OCF(TTM)0.55
OCFY2.72%
SpS3.75
BVpS6.48
TBVpS-1.41
PEG (NY)2.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.66%
ROCE 1.7%
ROIC 1.34%
ROICexc 1.46%
ROICexgc 9.36%
OM 4.61%
PM (TTM) N/A
GM 46.97%
FCFM 9.68%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y18.71%
ROICexcg growth 5YN/A
ROICexc growth 3Y10.74%
ROICexc growth 5YN/A
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 8.15
Debt/EBITDA 3.7
Cap/Depr 30.63%
Cap/Sales 5.11%
Interest Coverage 0.77
Cash Conversion 69.42%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.69
Altman-Z 2.77
F-Score7
WACC9.62%
ROIC/WACC0.14
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.34%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y17.8%
EPS Next 2Y18.39%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.25%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%4.88%
Revenue Next Year6.82%
Revenue Next 2Y7.2%
Revenue Next 3Y7.15%
Revenue Next 5YN/A
EBIT growth 1Y707.58%
EBIT growth 3Y33.25%
EBIT growth 5Y-1.65%
EBIT Next Year381.68%
EBIT Next 3Y85%
EBIT Next 5YN/A
FCF growth 1Y1193.51%
FCF growth 3Y18.28%
FCF growth 5YN/A
OCF growth 1Y408.7%
OCF growth 3Y22.74%
OCF growth 5Y46.47%